Abstract P6-16-02: Cost-effectiveness of endocrine therapy or radiation treatment alone or in combination for standard- and good-risk DCIS
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs19-p6-16-02
Abstract: Introduction: Ductal carcinoma in situ (DCIS) accounts for 20% of breast cancer cases in the United States and is potentially overtreated leading to high expenditures and low-value care. We conducted a first-of-its-kind cost-effectiveness analysis evaluating… read more here.
Keywords: risk; risk dcis; treatment; good risk ... See more keywords